Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Acad Emerg Med ; 8(9): 873-9, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11535479

ABSTRACT

OBJECTIVE: To compare the efficacy of droperidol with that of prochlorperazine for the treatment of benign headaches in emergency department (ED) patients. METHODS: Prospective, randomized clinical trial in an urban ED. Patients were given either droperidol, 5 mg intramuscular (IM) or 2.5 mg intravenous (IV), or prochlorperazine, 10 mg IM or 10 mg IV. Measurements included side effects and the patient's pain perception as measured on a 100-mm visual analog scale (VAS) at baseline, 30, and 60 minutes after the medication was given. Data were analyzed using chi-square, two-tailed t-tests, and two-way analysis of variance (ANOVA) when appropriate. RESULTS: During an eight-month period, 168 patients were enrolled. Eighty-two (48.8%) of the patients received droperidol; 86 (51.2%) received prochlorperazine. In the droperidol group, 49 (59.6%) received IM administration and 33 (40.4%) IV. In the prochlorperazine group, 57 (66.3%) received IM administration and 29 (33.7%) IV. Sixty minutes after the medication, the mean decrease in the VAS scores was 81.4% for droperidol and 66.9% for prochlorperazine (p = 0.001). At 30 minutes, 60.9% of the patients receiving droperidol and 44.2% of the patients receiving prochlorperazine had obtained at least a 50% reduction in their VAS scores (p = 0.09). At 60 minutes, 90.2% of the patients receiving droperidol and 68.6% of the patients receiving prochlorperazine had at least a 50% reduction in their VAS scores (p = 0.017). No difference between IM dosing and IV dosing was detected. Side effects, including dystonia, akathisia, and decreased level of consciousness, were seen in 15.2% of the patients receiving droperidol and 9.61% of the patients receiving prochlorperazine. No significant or persisting morbidity was detected. CONCLUSIONS: Droperidol was more effective than prochlorperazine in relieving pain associated with benign headaches.


Subject(s)
Dopamine Antagonists/therapeutic use , Droperidol/therapeutic use , Emergency Service, Hospital , Headache/drug therapy , Prochlorperazine/therapeutic use , Adult , Analysis of Variance , Dopamine Antagonists/administration & dosage , Dopamine Antagonists/adverse effects , Droperidol/administration & dosage , Droperidol/adverse effects , Female , Humans , Injections, Intramuscular , Injections, Intravenous , Male , Middle Aged , Pain Measurement , Prochlorperazine/administration & dosage , Prochlorperazine/adverse effects , Treatment Outcome
2.
Talanta ; 44(5): 939-45, 1997 May.
Article in English | MEDLINE | ID: mdl-18966823

ABSTRACT

We present a simple method of protecting a Cd(II) ion-selective electrode from fouling using a dialysis membrane. Drift due to fouling is inevitable during continuous exposure of the electrode to the bulk solution. It presents a major problem in the case of automated titrations because recalibration is not possible. The drift is due to natural organic matter present in the sediment, and the membrane prevents its accumulation on the electrode surface. This was verified by calibrating a Cd electrode exposed to sediment for varying times, both with and without a membrane covering. There are two types of time dependent biases. A primary drift occurs without exposure to sediments and is probably caused by oxidation of the surface. A more important effect due to natural organic matter accumulation causes additional drift and deteriorates the Nernstian response of the electrode. From these results, it is possible to predict the uncertainty associated with measurements of binding constants and surface site densities for a Langmuir model. In general, the biased electrode overestimates the total metal concentration, reduces the value of the stability constants and increases estimates of maximum surface site densities.

SELECTION OF CITATIONS
SEARCH DETAIL
...